aldesleukin,ict01
imcheck therapeutics,prometheus bio,iovance,novartis
['ict01', 'eviction-2', 'imcheck']
imcheck achieves the primary objectives of phase i of the eviction-2 trial of ict01 in combination with low dose il-2, data presented at aacr 2023 
We provide a balanced view on small cap biotech equities.